Auriga Reiterates a 'Buy' on MedAssets (MDAS); Positive Events Continue to Confirm Thesis
Tweet Send to a FriendGet Alerts MDAS Hot Sheet
Price: $17.47 +1.22%
Rating Summary:
11 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
11 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade MDAS Now!
Auriga reiterates a 'Buy' on MedAssets (NASDAQ: MDAS) price target of $16.00.
Auriga analyst said, "A confluence of recent positive events in the last four weeks leads us to reiterate our bullish view on MedAssets at current levels. While execution risk continues as the Company overhauls its revenue cycle business, and the burdensome debt load is hard to ignore, we believe MDAS is digging itself out in a methodical fashion. Though the stock is up some 35% in the latest three months, we still envision 20%+ upside to our $16 target. Next week's annual Health Business Summit, which features a track where the CFO and select MDAS customers will meet with a group of investors and analysts, could provide a catalyst for further gains."
For an analyst ratings summary and ratings history on MedAssets click here. For more ratings news on MedAssets click here.
Shares of MedAssets closed at $13.12 yesterday, with a 52 week range of $8.52-$16.28.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Auriga analyst said, "A confluence of recent positive events in the last four weeks leads us to reiterate our bullish view on MedAssets at current levels. While execution risk continues as the Company overhauls its revenue cycle business, and the burdensome debt load is hard to ignore, we believe MDAS is digging itself out in a methodical fashion. Though the stock is up some 35% in the latest three months, we still envision 20%+ upside to our $16 target. Next week's annual Health Business Summit, which features a track where the CFO and select MDAS customers will meet with a group of investors and analysts, could provide a catalyst for further gains."
For an analyst ratings summary and ratings history on MedAssets click here. For more ratings news on MedAssets click here.
Shares of MedAssets closed at $13.12 yesterday, with a 52 week range of $8.52-$16.28.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Janney Capital Trims Numbers on Buckle (BKE), Margins Peaking
- Needham & Company Lifts Numbers on Marvell (MRVL) on Solid Results
- Deutsche Bank Resumes CenterPoint Energy (CNP) at Hold
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Auriga
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
